

Scientists at MD Anderson Cancer Center are testing a breakthrough cell therapy that could finally bring hope to patients with hard-to-treat T-cell lymphoma.

The new approach overcomes a major obstacle that previously made this personalized cancer treatment impossible for these patients.

Want to know more?